Loading clinical trials...

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT00003025

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to and kill tumor cells. Combining vaccine therapy with surgery may be an effective treatment for pancr...

Lead sponsor: Memorial Sloan Kettering Cancer Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more

RECRUITINGNA

Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions

NCT07656571 · Pancreatic Neoplasms, Pancreatic Cancer

RECRUITINGNA

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT07651358 · Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, and more

RECRUITINGEARLY Phase 1

Lidocaine Infusion in Pancreatic Cancer

NCT04048278 · Pancreatic Cancer

RECRUITINGPhase 1

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT05076760 · Solid Tumor, Advanced Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 3, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment16

Start dateMar 1997

Last updatedJul 3, 2013

Condition

Pancreatic Cancer

Locations shown

Memorial Sloan-Kettering Cancer Center

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 3, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Lidocaine Infusion in Pancreatic Cancer

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Trial snapshot

Condition

Locations shown

For caregivers